These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12113126)

  • 1. FDA approves Novartis' Gleevec.
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):3. PubMed ID: 12113126
    [No Abstract]   [Full Text] [Related]  

  • 2. New leukemia drug receives FDA approval.
    Mayo Clin Health Lett; 2001 Jul; 19(7):4. PubMed ID: 11433951
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA approves Gleevec for pediatric leukemia.
    FDA Consum; 2003; 37(4):6. PubMed ID: 12971334
    [No Abstract]   [Full Text] [Related]  

  • 4. Gleevec approved for first-line treatment of CML.
    FDA Consum; 2003; 37(2):5. PubMed ID: 12715753
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves Gleevec for leukemia treatment.
    FDA Consum; 2001; 35(4):6. PubMed ID: 11692893
    [No Abstract]   [Full Text] [Related]  

  • 6. New leukemia drug shows promise against Gleevec resistance.
    Ashraf H
    Drug Discov Today; 2005 Apr; 10(7):453-4. PubMed ID: 15809187
    [No Abstract]   [Full Text] [Related]  

  • 7. Gleevec (STI-571) for chronic myeloid leukemia.
    Med Lett Drugs Ther; 2001 Jun; 43(1106):49-50. PubMed ID: 11402258
    [No Abstract]   [Full Text] [Related]  

  • 8. Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.
    Johnson JR; Bross P; Cohen M; Rothmann M; Chen G; Zajicek A; Gobburu J; Rahman A; Staten A; Pazdur R
    Clin Cancer Res; 2003 Jun; 9(6):1972-9. PubMed ID: 12796358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quick success for cancer kinase treatment.
    Nat Med; 2001 Jun; 7(6):637. PubMed ID: 11385473
    [No Abstract]   [Full Text] [Related]  

  • 10. Gleevec for the treatment of chronic myelogenous leukemia: US. Food and Drug Administration regulatory mechanisms, accelerated approval, and orphan drug status.
    Cohen MH; Moses ML; Pazdur R
    Oncologist; 2002; 7(5):390-2. PubMed ID: 12401900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STI-571 (Gleevec) in the treatment of chronic myeloid leukaemia.
    Kumar L; Kumari M; Menon H
    Natl Med J India; 2002; 15(5):298. PubMed ID: 12502149
    [No Abstract]   [Full Text] [Related]  

  • 12. A cancer 'smart bomb'. A new drug shows hope of conquering a form of leukemia by targeting the misbehaving cells.
    Kalb C
    Newsweek; 2000 Dec; 136(25):68. PubMed ID: 11126146
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer's mechanics. Targeting errant cells.
    Sobel RK
    US News World Rep; 2001 May; 130(20):54. PubMed ID: 11383095
    [No Abstract]   [Full Text] [Related]  

  • 14. Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST).
    Hochhaus A
    Ann Hematol; 2004; 83 Suppl 1():S65-6. PubMed ID: 15124676
    [No Abstract]   [Full Text] [Related]  

  • 15. Restoration of insulin sensitivity following treatment with imatinib mesylate (Gleevec) in non-diabetic patients with chronic myelogenic leukemia (CML).
    Tsapas A; Vlachaki E; Sarigianni M; Klonizakis F; Paletas K
    Leuk Res; 2008 Apr; 32(4):674-5. PubMed ID: 17920117
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gleevec: an novel inhibitor of bcr-abl tyrosine kinase].
    Guo XN; Ding J
    Sheng Li Ke Xue Jin Zhan; 2003 Apr; 34(2):183-6. PubMed ID: 12889162
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction: chronic myelogenous leukemia (CML).
    Jabbour E; Kantarjian H
    Semin Hematol; 2007 Jan; 44(1 Suppl 1):S1-3. PubMed ID: 17292735
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypolipemiant besides antileukemic effect of imatinib mesylate.
    Gologan R; Constantinescu G; Georgescu D; Ostroveanu D; Vasilache D; Dobrea C; Iancu D; Popov V
    Leuk Res; 2009 Sep; 33(9):1285-7. PubMed ID: 19327828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attentive questions about treatment of chronic myelogenous leukemia with imatinib mesylate].
    Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):433-5. PubMed ID: 17147242
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes research. Researchers puzzle over possible effect of Gleevec.
    Couzin J
    Science; 2005 Mar; 307(5716):1711. PubMed ID: 15774738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.